Antonio C. Wolff
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.02%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Oncology 193
- HER2/EGFR in Cancer Research 83
- Cancer Treatment and Pharmacology 42
- Cancer survivorship and care 31
- Cancer Research 127
- Breast Cancer Treatment Studies 102
- Cancer Genomics and Diagnostics 20
- Co-authors
- Mitch Dowsett (12 shared papers)Kimberly H. Allison (11 shared papers)Lisa M. McShane (9 shared papers)Pamela B. Mangu (5 shared papers)M. Elizabeth Hammond (9 shared papers)Daniel F.C. Hayes (12 shared papers)Giuseppe Viale (10 shared papers)Patrick L. Fitzgibbons (6 shared papers)
- Journals
- Journal of Clinical Oncology (76 papers)Breast Cancer Research and Treatment (26 papers)Clinical Cancer Research (18 papers)Annals of Oncology (14 papers)Journal of the National Comprehensive Cancer Network (13 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Antonio C. Wolff
354 papers receiving 45.7k citations
Antonio C. Wolff's Hit Papers
Peers
Comparison fields: 5 of 176
- Cancer Research 16.0k
- Oncology 21.8k
- Radiology, Nuclear Medicine and Imaging 5.1k
- Pulmonary and Respiratory Medicine 6.6k
- Pathology and Forensic Medicine 3.5k
Countries citing papers authored by Antonio C. Wolff
This map shows the geographic impact of Antonio C. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio C. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio C. Wolff more than expected).
Fields of papers citing papers by Antonio C. Wolff
This network shows the impact of papers produced by Antonio C. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio C. Wolff. The network helps show where Antonio C. Wolff may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio C. Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 366 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Hit paper breakdown → | 2006 | 3921 |
| 2 | American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer Hit paper breakdown → | 2010 | 3619 |
| 3 | Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Hit paper breakdown → | 2013 | 3417 |
| 4 | Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Hit paper breakdown → | 2018 | 1825 |
| 5 | American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Hit paper breakdown → | 2007 | 1548 |
| 6 | American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Hit paper breakdown → | 2005 | 1499 |
| 7 | Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Hit paper breakdown → | 2013 | 1445 |
| 8 | 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline Hit paper breakdown → | 2006 | 1289 |
| 9 | Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Hit paper breakdown → | 2018 | 1173 |
| 10 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 Hit paper breakdown → | 2014 | 1069 |
| 11 | Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update Hit paper breakdown → | 2020 | 1053 |
| 12 | American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version) Hit paper breakdown → | 2010 | 907 |
| 13 | American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer Hit paper breakdown → | 2010 | 816 |
| 14 | American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004 Hit paper breakdown → | 2004 | 814 |
| 15 | 2008 | 779 | |
| 16 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer Hit paper breakdown → | 2015 | 559 |
| 17 | 2010 | 518 | |
| 18 | Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Hit paper breakdown → | 2016 | 499 |
| 19 | Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2012 | 482 |
| 20 | 2006 | 437 |
About Antonio C. Wolff
Antonio C. Wolff is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 366 papers that have together received 47.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (102 papers), HER2/EGFR in Cancer Research (83 papers), Cancer Treatment and Pharmacology (42 papers), Advanced Breast Cancer Therapies (39 papers), Cancer survivorship and care (31 papers), Estrogen and related hormone effects (26 papers), Cancer Genomics and Diagnostics (20 papers) and Medical Imaging Techniques and Applications (13 papers). The work is most often cited by research in Cancer Research (16.0k citations), Oncology (21.8k citations), Radiology, Nuclear Medicine and Imaging (5.1k citations), Pulmonary and Respiratory Medicine (6.6k citations) and Pathology and Forensic Medicine (3.5k citations). Antonio C. Wolff has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Mitch Dowsett, Kimberly H. Allison, Lisa M. McShane, Pamela B. Mangu, M. Elizabeth Hammond, Daniel F.C. Hayes, Giuseppe Viale, Patrick L. Fitzgibbons, Patricia A. Spears and Edith A. Perez. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research, Annals of Oncology and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.